Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | KDM5A | P29375 | 2/20 | 0.42 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627757 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL116822 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL20711482 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24372535 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL4891576 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24473984 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24113636 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24728617 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL20979308 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL14839985 | 1.00 | DNM1 (0.55) | DNM1TSHRTHRBKDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116348084-A | Cosmetic compositions, kits, and methods of making and using the same | 莱雅公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116018127-A | Cosmetic compositions, kits, and methods of making and using the same | 莱雅公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-113301965-A | Hair care system, hair care method and use of hair care system | 欧莱雅 | 2021-08-24 | — | — | CN | disclosed |
| CN-113271917-A | Hair care and conditioning composition | 莱雅公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20140170175-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | AXOLABS GMBH (DE) | 2014-06-19 | — | — | US | disclosed |
| US-20140170175-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | AXOLABS GMBH (DE) | 2014-06-19 | — | — | US | disclosed |
| US-20120295832-A1 | Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds | ARROWHEAD RESEARCH CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120295832-A1 | Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds | ARROWHEAD RESEARCH CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-7067697-B2 | Cationic liposomes for gene transfer | VANDERBILT UNIVERSITY (US) | 2006-06-27 | — | — | US | disclosed |
| US-20060057194-A1 | Cationic liposomes for gene transfer | GAO XIANG | 2006-03-16 | — | — | US | disclosed |
| US-7002042-B2 | Cationic liposomes for gene transfer | VANDERBILT UNIVERSITY (US) | 2006-02-21 | — | — | US | disclosed |
| US-6656498-B1 | Cationic liposomes for gene transfer | VANDERBILT UNIVERSITY | 2003-12-02 | — | — | US | disclosed |
| US-20030049310-A1 | Cationic liposomes for gene transfer | VANDERBILT UNIVERSITY | 2003-03-13 | — | — | US | disclosed |
| WO-2000030444-A1 | CATIONIC LIPOSOMES FOR GENE TRANSFER | VANDERBILT UNIVERSITY (US) | 2000-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060057194-A1 | Cationic liposomes for gene transfer | LCLAT1, LPCAT3, LPCAT1 | DNM1 778/4885TSHR 3205/4885THRB 2303/4885 |
| US-20140170175-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | PHOSPHO1, NPC1L1, PLIN3 | DNM1 408/4885TSHR 4444/4885THRB 3881/4885 |
| US-20120295832-A1 | Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds | PHOSPHO1, NPC1L1, PLIN3 | DNM1 408/4885TSHR 4444/4885THRB 3881/4885 |
| US-20030049310-A1 | Cationic liposomes for gene transfer | LCLAT1, LPCAT3, LPCAT1 | DNM1 778/4885TSHR 3205/4885THRB 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.